dividing haemopoietic cells of non-lymphoid lineages and, in some patients, also in B lymphocytes.
Ph+ CML patients in chronic phase. We now report the approved by the local ethical committee and patients or their legal guardians gave informed consent before entry results of this pilot study after a follow-up of 3-7 years.
into the study.
Patients and methods

Culture assays
Standard LTBMC were established in 25 cm 2 tissue flasks Eligibility with a preliminary sample of marrow from each patient to The following criteria were applied: (1) Ph+ CML in evaluate the genotype of clonogenic cells and mature end chronic phase; (2) Ͻ50 years old; (3) lack of an HLAcells. Cells were inoculated in a 10 ml volume of culture matched sibling donor; and (4) previous evidence in longmedium at a concentration of 2 × 10 6 nucleated cells/ml and term bone marrow cultures (LTBMC) of the presence of the cultures were maintained for 4-5 weeks. At weekly residual Ph− progenitors and depletion of Ph+ progenitors feeding the content of clonogenic cells, including those (see Results). All patients were required to have adequate originating multilineage (CFU-GEMM), erythroid (BFU-E) renal, hepatic, pulmonary and cardiac function.
and granulocyte-macrophage colonies (GM-CFC), was determined. The methodology of the LTBMC system and of clonogenic assay has been described in detail elsePatients where.
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Of the CML patients who had their marrow assessed in LTC, 20 (40% of the total) met the culture criteria (see Cytogenetic analyses Results) used for entry in this study. 21 A clinical summary of the nine CML patients who subsequently received their
We used conventional cytogenetic methods to obtain metacultured marrow following myeloablative chemotherapy phase spreads of marrow aspirates and of non-adherent between February 1989 and January 1993 is found in cells from LTBMC. In addition, metaphase preparations Table 1 . There were six males and three females with an were made of colonies, predominantly of the GM-CFC age range of 9-48 years (median 38). The median interval lineage, as described before. 25 Colonies were plucked out from diagnosis to autograft was 15 months . Before individually or were pooled from the entire culture dish. the transplant all patients, except one initially managed with Preparations were Giemsa banded before analysis. busulphan, were treated with hydroxyurea (HU) alone at intermittent high doses, or at conventional doses in combiPre-transplant schedule and conditioning regimen nation with IFN-␣ or with thioguanine (one case). None of the four patients who received IFN-␣ therapy for [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] On day −10 marrow was harvested under general anaesmonths had had a complete or major cytogenetic response.
thesia and allopurinol and anti-fungal prophylaxis started. IFN was stopped at least 1 month before collection of marOn days −9 and −5, respectively, prophylactic treatment row for culture, and if necessary, patients were managed in was started with co-trimoxazole against Pneumocystis carithe meantime with conventional doses of HU. Four patients nii and with acyclovir against viral infections. referred to the centre as newly diagnosed were treated with Patients were conditioned with a regimen of busulphan pulse high-dose HU as the recommended regimen with a administered orally at 1 mg/kg every 6 h on days −9 to −6, view to performing autografting with cultured cells. This followed by cyclophosphamide given intravenously on days was based on data 21, 22 showing that pulse HU has a selec-−5 and −2 at 50 mg/kg per day with mesna and an adequate tive effect on Ph− haemopoiesis in CML which results in hydration regimen to prevent uroepithelial toxicity. improved recovery of Ph− cells from LTC (see Results).
Details of dose and schedule have been previously
Processing and culture of marrow for autografting reported. 23 None of the patients selected for culture autografting had undergone splenectomy. The protocol was A volume of 1.0-1.5 l of marrow was aspirated from the posterior iliac crests under general anaesthesia to aim for a collection of about 4 × 10 8 /kg body weight. The aspirated in LTC to assess the presence of residual Ph− cells and the All culture procedures were carried out in a designated degree of cytogenetic conversion within 4-5 weeks. The room with positive pressure filtered air ventilation in level populations assessed were developing non-clonogenic cells II microbiological safety cabinets. After 10 days of culture and also colony-forming cells (mainly from the supernatant the adherent layer of each flask was detached by mechanof the cultures). We made the assumption that an enrichical scraping with a 'rubber policeman' and collected ment of Ph− cells in such mature populations after that time together with the non-adherent cell suspension. The conin culture would mirror the selection of a primitive haemotents of 20 flasks were pooled at a time and transferred to poietic cell population of similar genotype, present in the a 2 l Fenwal transfer bag (R2041 Travenol, Norfolk, UK).
initial inoculum and preserved for at least 10 days. Patients The cells were washed in IMDM on a COBE 2991 blood were considered eligible if the percentage of Ph− cells was cell processor and the final volume of the total proof у75% in colony preparations by 3 weeks in culture reduced to 200-300 ml. The final pool was loaded into a (Table 2) . However, for patients in whom culture cyto-600 ml transfer pack (R2021 Travenol) containing 2% (v/v) genetic preparations were only obtained from supernatant autologous serum and infused into the patient via the intramononuclear cells, a conversion of Ͼ50% Ph− metaphases venous long line without a filter. Minor reactions of fever at 3 weeks was considered adequate. This was based on and chills occurred occasionally and were managed with previous studies of the kinetics of Ph− restoration in the anti-histamine and hydrocortisone. different LTBMC cell compartments (with the content of An aliquot of each cultured autograft was taken for normal genotype in the dividing supernatant mononuclear assessment of incidence of GM-CFC, and in the last cases, cell population being on average a third of that of the clonofor evaluation of Mk-CFC numbers in the relevant clonogenic cells).
21
genic assays.
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Four of these patients (UPNs 891, 892, 912 and 921) The incubation period of 10 days was chosen based on initially failed the culture criteria to enter the study since our previous experience of cultured autografts in AML their marrow showed marginal levels (2%) or no detectable patients who successfully reconstituted with karyotypically Ph− cells in LTBMC at diagnosis. These patients were put normal cells following myeloablative chemotherapy. 26, 27 on a regimen of pulse high-dose hydroxyurea and their marLater, a similar culture time was used in CML by the Vancouver group and it was shown to contain maximal numbers of selectively enriched normal (Ph−) stem cells. The management of these patients with regard to antibiotic usage, irradiated blood products and intravenous nutrition were obtained at the time of engraftment and thereafter at
17,28
In addition aliquots of autografts from three patients which were also assayed for megakaryocyte progenitors produced no colonies, despite the incidence of Mk-CFC in the original marrow harvest being within the normal range (4-25 per 10 5 mononuclear cells) (data not shown). One patient died of sepsis 1 month after the autograft before any signs of engraftment occurred. Another patient failed to engraft despite the infusion of the back-up marrow and died 3 months after the autograft. Evidence of myeloid engraftment was observed in seven patients, with normal (or near normal) blood counts being subsequently achieved in all. One case had prolonged thrombocytopenia of Ͼ1 year duration, which proved to be fatal. The median time for the recovery of neutrophils to 0.5 ϫ 10 9 /l in seven patients was 26 days (range 15-39), and for the recovery (Table 3 ).
or pooled colonies from LTC established with a diagnostic sample (S1 = at 2-4 weeks) and from LTC established 5-7 days after a pulse of high-dose HU (S2 = at 2-4 weeks and S3 = at 5 weeks). For comparison the same
Time-course cytogenetic analyses
cell population (either supernatant mononuclear cells, pooled colonies from the supernatant or pooled colonies from the adherent layer) was ana- Table 4 shows the cytogenetic results of the original bone lysed after similar time in culture of flasks established from the same marrow harvest, the reinfused cultured cell suspension and individual before and after HU therapy, as previously reported.
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of follow-up marrow samples obtained after the autograft.
The infused cells were in most patients still predominantly row re-assessed in LTBMC after 2-5 months of treatment.
Ph+. However, these are mainly mature end cells and as This time they all showed a high degree of cytogenetic consuch are distant in the differentiation pathway from the version to Ph− haemopoiesis following LTBMC (Figure 1) .
long-term culture-initiating cells (LTC-IC), which are In two cases, 57% and 90% Ph− metaphases were obtained thought to overlap or be closer to the cells responsible for from preparations of supernatant mononuclear cells (UPNs long-term engraftment. Although the number of LTC-IC 891 and 921), and in the other two colony cytogenetic prepinfused was not measured, 29 the cytogenetic profile of the arations showed 79% and 93% Ph− metaphases (UPNs 892 progeny of these cells (ie clonogenic cells from 4-to 5-and 912). Repeated samples were obtained later and conweek-old LTC) was shown to be predominantly Ph− (data tinued to show similar levels of cytogenetic response in not shown). This was reflected in the composition of the LTBMC even after 4-14 months of pulse HU therapy marrow at the time of engraftment, with four patients show-( Table 2) .
ing exclusively (100%) Ph− haemopoiesis and three having predominantly (71-92%) Ph− cells.
Cell dose and time of engraftment
The duration of complete Ph− haemopoiesis ranged from 6 to 12 months. IFN therapy was started at 6-12 months With an average reduction in culture of 50% of the original cell inoculum, the autograft after 10 days in culture after autografting, except for one case (UPN 891) who received IFN at the return to clinically apparent chronic contained a median of 2.4 × 10 8 nucleated cells/kg body weight (range 1-4). The median GM-CFC dose was phase. For those who were started earlier on IFN, the Ph+ clone continued to increase in two (UPNs 901 and 911), 6.5 × 10 4 cells/kg body weight (range 0.9-36) representing only 0.02% of the total nucleated cells infused (Table 3) .
while in three who actually had not reconstituted with Outcome and survival Discussion The survival and present status of each patient at the last follow-up (May 1996) is described in Table 5 . There were Our study confirms that autografts of cultured marrow in CML result in a high rate of marrow reconstitution with three transplant-related deaths: two patients died of graft failure at 1 and 3 months post-autograft, and one died of entirely or predominantly Ph− cells and a prolonged period of cytogenetic remission in some patients.
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cerebral vascular accident as a consequence of profound thrombocytopenia at 16 months. This patient then had 97% Although we have not quantitatively evaluated the numbers of Ph− LTC-IC and their leukaemic counterparts after Ph− haemopoiesis.
Three patients reverted to chronic phase and 100% Ph+ 10 days in culture for the infused autograft or as part of the pre-harvest evaluation, our indirect assessment of these haemopoiesis at 27 (UPN 891) and 36 (UPNs 901 and 911) months post-autograft. Unrelated HLA-matched donors progenitor populations proved to be adequate to predict engraftment with total or predominantly Ph− cells. The culwere found for two (UPNs 901 and 911) and in a second attempt to cure their disease, MUD transplants were carried ture criteria for eligibility were a minimum content of у75% Ph− metaphases from colony (GM-CFC) prepout at 43 and 46 months respectively after the autograft. Unfortunately both succumbed to infection and died 7 and arations or Ͼ50% Ph− metaphases from supernatant mononuclear cells at 3 weeks. This would entail, by the kinetics 12 months later.
Four patients are alive 40-87 months post-autograft: one of Ph− conversion in LTBMC, 18 a greater percentage still CVA = cerebral vascular accident; Rel = relapse; CP = chronic phase; MUD = matched unrelated donor; ARSD = acute respiratory distress syndrome; CCR = complete cytogenetic remission; HR = haematologic remission. a Defined as the time up to the first cytogenetic evaluation with Ph− cells being Ͻ50%.
of Ph negativity by 5 weeks. Since at 5 weeks, the GMparison is made with autografts of PBPC with a median time for neutrophil recovery being 8-11 days more pro-CFC cells are not part of a pre-existing GM-CFC population, but are derived from a primitive progenitor cell longed than the latter. 14, 31 In addition, recovery of platelets was rather slow. The absence in culture from three patients population (ie the LTC-IC), 30 the conversion to maximal or total Ph− haemopoiesis among the former cells would of megakaryocyte progenitors after 10 days raises the possibility that the conditions of the system might select against suggest a large differential in the relative numbers of Ph− and Ph+ LTC-IC in the initial inoculum. This differential megakaryocytes. However, the identification of thrombopoietin may allow improvements in the survival and develbecomes even greater after 10 days in culture, because the maintenance of leukaemic LTC-IC is very compromised in opment of megakaryocyte progenitors in vitro, and thus reduce the period of thrombocytopenia following cultured such conditions compared to normal (Ph−) LTC-IC cells.
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By using a quantitative assessment of the content of autografts. Laboratory and clinical studies along these lines and to further improve purging 36 are now being carried out. primitive progenitors after 10 days in LTBMC with a minimum requirement of 20 Ph− LTC-IC per 2.5 × 10 7 initial Importantly, in this study, reconstituted haemopoiesis was sustained with no occurrence of late graft failure, suggestmarrow cells and the numbers of Ph+ stem cells being less than the limit of the sensitivity of the assay, it is possible ing that engraftment with cultured autografts was mediated by haemopoietic stem cells. that Barnett et al 17 have selected a better group of patients, ie with a greater reserve of normal marrow than the cohort Durable Ph− haemopoiesis has been reported to occur after unmanipulated autografts of marrow or peripheral of patients selected in this study. The greater percentage of evaluable cases reported by Barnett et al 17 who reconstiblood. [33] [34] [35] In those cases, however, restoration to Ph− haemopoiesis is reported to occur sporadically and only 4 tuted with entirely Ph− haemopoiesis (13 out of 16, 81%) compared to the one in this study (four out of seven, 57%) months to 2 years after the autograft. This suggests that the origin of Ph− haemopoiesis is endogenous rather than is consistent with this postulate. Recently, the degree of Ph− haemopoiesis in the reconstituting marrow after transautograft-derived. In addition, haemopoietic reconstitution in conventional autografts is mainly with Ph+ cells. Thus, plantation has been shown to correlate with the percentage of Ph− cells in the infused autograft. 31 However, the other the speed and the high rate of Ph− reconstitution in our series of patients, together with an absence of late appearthree evaluable patients in this study still attained high levels of Ph negativity (71-92%) as reported for the remaining ance of Ph− cells, strongly suggest, as previously reported 17 that Ph− haemopoiesis in recipients of cultured autografts three patients (75-94% Ph− cells) in the Vancouver study. Therefore, all patients in our study who successfully is mainly, if not all, culture-derived. Another procedure generating wide interest as an effecengrafted showed a regenerating marrow with only or mainly Ph− cells.
tive treatment to induce durable complete cytogenetic remission in CML is the autografting of PBPC collected in Data presented here and in a previous report show that treatment with pulse high-dose HU prior to harvest helped the recovery phase of chemotherapy-induced aplasia. 14 This group reported that five out of the seven evaluable patients four patients to achieve the degree of Ph negativity in LTBMC considered necessary for the autograft proreconstituted with Ph− haemopoiesis and remained in complete cytogenetic remission during the 8-12 months of the gramme. 21 Others utilising a similar regimen of high-dose HU have also observed marked suppression of the Ph+ autograft follow-up. 37 Nevertheless, others have not been able to reproduce these results due to considerable technical clone in three out of five patients which allowed collection of predominantly normal cells by leukapheresis. 32 In and logistic difficulties such as complications of myelosuppression requiring frequent hospitalizations, unpredictaddition, we have previously shown that IFN-␣ therapy in early stage disease is associated with a significantly higher able time of mobilization necessitating repeated out-patient visits and resulting in the Ph negative 'window' being misnumber of patients who show a major degree of Ph− conversion (у50% Ph− cells) in LTBMC compared to sed or low number of progenitor cells being collected. 38 Relapse is the major cause of treatment failure in autountreated patients, even in cytogenetic non-responders. 21 It is possible then to increase the proportion of eligible CML logous transplantation due to graft contamination and lack of graft-versus-leukaemia reactions. The former issue may patients for this procedure by using these additional therapeutic regimens to reduce the leukaemic burden in vivo at least in part be addressed by 'purging' techniques. However, the lack of immunological effector cells still remains, prior to LTBMC purging.
Three patients died due to procedure-related toxicity posing a greater risk for relapse than in syngeneic transplants which are associated with 50% relapse rate. 39 The (33% mortality), two of these as a consequence of graft failure. The incidence of graft failure (22%) was similar to duration of complete cytogenetic responses in this study ranged from 6 to 12 months. This is comparable with the that reported by Barnett et al 17 (23%), and no different from the rates of graft failure in recipients of autografts or perperiod of complete cytogenetic remission reported by others using purged autografts. [15] [16] [17] 31 In three patients of the ipheral blood mononuclear cells (19-21%), 33, 34 or in autologous transplantation of PBPC collected in the recovery present series, cytogenetic relapse was associated with the return to chronic phase, but none progressed to blast phase phase of myelosuppressive treatment (19% to 22%).
14, 31 The time of haematological recovery in the present study disease within the 4-7 years following the autograft and 6.5-8 years since diagnosis. This exceeds the median durwas very similar to that reported previously for patients who received cultured autografts 17 and for recipients of ation of chronic phase in CML suggesting that these patients might have benefited from the treatment. In another unmanipulated marrow autografts. 33, 35 On the other hand, the speed of haematological reconstitution was slow if comthree patients, IFN-␣ introduced 6-12 months post-auto- 
